C45H33Cl2F6N9O6 — CID 161092909
4-amino-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one;chloromethane;4-chloro-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one (PubChem CID 161092909) has the molecular formula C45H33Cl2F6N9O6 and a molecular weight of 980.71 g/mol. Its IUPAC name is 4-amino-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one;chloromethane;4-chloro-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one.
| Compound Name | 4-amino-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one;chloromethane;4-chloro-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one |
|---|---|
| PubChem CID | 161092909 |
| Molecular Formula | C45H33Cl2F6N9O6 |
| Molecular Weight | 980.71 g/mol |
| Exact Mass | 979.18 |
| IUPAC Name | 4-amino-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one;chloromethane;4-chloro-6-[1-[3-(trifluoromethoxy)phenyl]indol-5-yl]-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5-one |
| SMILES | CCl.Nc1ncnc2c1C(=O)N(c1ccc3c(ccn3-c3cccc(OC(F)(F)F)c3)c1)CCO2.O=C1c2c(Cl)ncnc2OCCN1c1ccc2c(ccn2-c2cccc(OC(F)(F)F)c2)c1 |
| InChI | InChI=1S/C22H14ClF3N4O3.C22H16F3N5O3.CH3Cl/c23-19-18-20(28-12-27-19)32-9-8-30(21(18)31)15-4-5-17-13(10-15)6-7-29(17)14-2-1-3-16(11-14)33-22(24,25)26;23-22(24,25)33-16-3-1-2-14(11-16)29-7-6-13-10-15(4-5-17(13)29)30-8-9-32-20-18(21(30)31)19(26)27-12-28-20;1-2/h1-7,10-12H,8-9H2;1-7,10-12H,8-9H2,(H2,26,27,28);1H3 |
| InChIKey | UHKLZEYRQFWZRD-UHFFFAOYSA-N |
| XLogP | 9.81 |
| TPSA | 164.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 68 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 980.71 |
| LogP ≤ 5 | 9.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 13 |
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|